A qualitative comparison of how older breast cancer survivors process treatment information regarding endocrine therapy.

ABSTRACT:

Background

It remains unclear how information about aromatase inhibitors (AI) impacts women's decision-making about persistence with endocrine therapy.

Purpose

To describe and compare how women treated for primary early stage breast cancer either persisting or not persisting with an AI received, interpreted, and acted upon AI-related information.

Design

Thematic analysis was used to sort and compare the data into the most salient themes.

Participants

Women (N = 54; 27 persisting, 27 not persisting with an AI) aged 65-93 years took part in qualitative interviews.

Results

Women in both subgroups described information similarly in terms of its value, volume, type, and source. Aspects of AI-related information that either differed between the subgroups or we

SUBMITTER: Pieters HC 

PROVIDER: S-EPMC6354984 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature